Article
COVID-19 prompts ‘democratization’ of cancer trials
Dr. Alan Lyss reviews a panel discussion about how COVID-19 has affected cancer research.
Article
CheckMate 9LA: ‘Doing better’ for stage IV/recurrent NSCLC
Dr. Alan P. Lyss explores the clinical implications of the CheckMate 9LA study.
News
Capmatinib shows impressive results in METex14-mutated NSCLC
Capmatinib produced durable responses, even in patients with brain metastases.
Article
ESMO provides road map for lung cancer care in the COVID-19 era
The holistic approach the ESMO guidelines promote has never been more critical than during the pandemic.
News
Advice from the front lines: How cancer centers can cope with COVID-19
The medical director of the Seattle Cancer Care Alliance offers advice for cancer centers dealing with COVID-19.